Ergoteles’s Pediatrix Medical MD Stock Holding History

Ergoteles’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-41,690	Closed	-$620K	–	1555
2022 Q4	$620K	Sell	41,690 -1,234	-3%	-$20.1K	0.02%	623
2022 Q3	$709K	Buy	+42,924	New	+$864K	0.02%	630
2021 Q4	–	Sell	-10,000	Closed	-$284K	–	1455
2021 Q3	$284K	Buy	+10,000	New	+$305K	0.01%	830
2020 Q4	–	Sell	-28,700	Closed	-$467K	–	813
2020 Q3	$467K	Buy	+28,700	New	+$534K	0.06%	243

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles's MD Position: Q1 2023 in Review

Ergoteles sold out of Pediatrix Medical (MD) in Q1 2023, closing a stake of 41,690 shares — an estimated $620K sold.

Ergoteles first reported a position in MD in Q3 2020 and held it in 4 quarters. The position peaked at $709K in Q3 2022. 214 funds tracked by Wall St. Rank hold MD as of Q1 2023.

Ergoteles reported no remaining Pediatrix Medical position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 41,690 Pediatrix Medical shares in Q1 2023, an estimated $620K.
Ergoteles first reported a position in Pediatrix Medical in Q3 2020 and held it in 4 quarters.
Ergoteles's Pediatrix Medical position peaked at $709K in Q3 2022.
214 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.